United States · FDA National Drug Code directory
CLENZIDERM PORE THERAPY ACNE TREATMENT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62032-612_7a1227cd-1bd0-4952-ae9e-d03d7c911b58
- Product NDC
- 62032-612
- Form
- LIQUID
- Composition / generic term
- SALICYLIC ACID
- Labeler
- Obagi Cosmeceuticals LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20070201
- Source listing expiry
- 20261231
Source-listed ingredients
- SALICYLIC ACID — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) · 62032-612-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →